Informative Note

Regulations on Licensing to Engage in Pharmaceutical Activity


Presidential Decree 41/24 of 29 January – Regulations on Licensing to Engage in Pharmaceutical Activity ("RLEAF") was recently published to establish the rules and procedures for licensing to engage in pharmaceutical activity. It also repeals Articles 8, 9, 11, 13, 47 and 49 of the Regulations on Engaging in Pharmaceutical Activity, approved by Presidential Decree 191/10, approved by Presidential Decree 191/10,  approved by Presidential Decree 191/10 of 1 September, and Presidential Decree 202/21 of 26 August.


Keep up to date

Please note, your browser is out of date.
For a good browsing experience we recommend using the latest version of Chrome, Firefox, Safari, Opera or Internet Explorer.